Researchers gain insight into metabolic pathways hijacked by SARS-CoV-2
SARS-CoV-2 diverts building blocks from glucose production to the assembly of purine bases, researchers have found.
List view / Grid view
SARS-CoV-2 diverts building blocks from glucose production to the assembly of purine bases, researchers have found.
A team have shown that a tumour-suppressing and killing molecule delivered to the brain by stem cells has been successful in mice.
Researchers have used a drug candidate to block a receptor that contributes to the development of autoimmune disease which could be a potential treatment.
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
Researchers have used single-cell sequencing to map the landscape of myeloid cells in tumours from patients with lung cancer...
New approach restores epithelial function in diarrhoea and inflammatory bowel disease models...
Preclinical study yields previously unreported, potent and generalisable hits representing potential drug targets for hereditary breast, ovarian cancer...
Researchers have designed a drug delivery capsule that can stay in the stomach for up to 1 month, and could sense and treat infections...
An immunoassay developed to analyse small molecules has shown 50 times greater accuracy than current systems of analytical techniques...
A comprehensive study reveals an expanding universe of 'darkest of the dark matter' RNAs in dopamine-producing cells in our brains...
Researchers have found that cancer cells evade destruction by macrophages in two ways...
Researchers report that in preclinical models they can amplify macrophage immune responses against cancer using a self-assembling supramolecule...
A study of 27,000 women finds that branched-chain amino acid levels in the bloodstream are as predictive of heart disease as LDL cholesterol, other risk factors...
A team of researchers set out to discover the disease pathways of a rare genetic kidney disease and found a compound that stops the disease in its tracks.
Non-invasive diagnostic tool measures circulating microRNAs to predict ovarian cancer with specificity...